Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder

• Main Authors: Tushar Saha (Author), Shubhra Sinha (Author), Rhodri Harfoot (Author), Miguel E. Quiñones-Mateu (Author), Shyamal C. Das (Author)
• Format: Book
• Published: MDPI AG, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

SARS-CoV-2, the causative agent of COVID-19, predominantly affects the respiratory tract. As a consequence, it seems intuitive to develop antiviral agents capable of targeting the virus right on its main anatomical site of replication. Ivermectin, a U.S. FDA-approved anti-parasitic drug, was origina...